January 22, 2026 – Talk Bio

Actionable Insights Powered by AI

FDA Issues Draft Guidance on MRD and CR Endpoints for Accelerated Multiple Myeloma Drug Approvals

9 hours ago talkbio0Tagged Accelerated, Advice, Approved, In complete remission, Multiple Myeloma, Neoplasm, Residual, United States Food and Drug Administration

FDA guidance; multiple myeloma; MRD; complete response; accelerated approval